For the quarter ending 2026-03-31, ATRA has $19,997K in assets. $57,309K in debts. $8,360K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Inventories | - | 0 | 0 | 0 |
| Cash and cash equivalents | 8,360 | 8,482 | 5,742 | 16,903 |
| Short-term investments | - | 0 | 7,970 | 5,420 |
| Restricted cash | - | 0 | 0 | 0 |
| Accounts receivable | 0 | 1,253 | 1,913 | 0 |
| Other current assets | 3,813 | 2,477 | 2,807 | 2,449 |
| Total current assets | 12,173 | 12,212 | 18,432 | 24,772 |
| Property and equipment, gross | - | 286 | 551 | - |
| Less accumulated depreciation and amortization | - | 213 | 404 | - |
| Property and equipment, net | 55 | 73 | 147 | 176 |
| Operating lease assets | 6,879 | 7,064 | 10,707 | 11,027 |
| Other assets | 890 | 886 | 881 | 927 |
| Total assets | 19,997 | 20,235 | 30,167 | 36,902 |
| Accounts payable | 637 | 127 | 318 | 1,762 |
| Accrued compensation | 629 | 1,271 | 2,067 | 2,552 |
| Accrued research and development expenses | 41 | 82 | 342 | 971 |
| Deferred revenue | 684 | 716 | 1,011 | 1,607 |
| Liability related to the sale of future revenues - current portion | 715 | 9,750 | 9,670 | - |
| Other current liabilities | 2,939 | 2,976 | 4,649 | 7,671 |
| Total current liabilities | 5,645 | 14,922 | 18,057 | 14,563 |
| Operating lease liabilities - long-term | 9,076 | 9,347 | 15,005 | 15,426 |
| Deferred revenue - long-term | - | - | - | 0 |
| Liability related to the sale of future revenues - long-term | 40,759 | 32,673 | 31,976 | 40,222 |
| Other long-term liabilities | 1,829 | 1,795 | 1,763 | 1,732 |
| Total liabilities | 57,309 | 58,737 | 66,801 | 71,943 |
| Common stock - 0.0001 par value, 500,000 shares authorized as of march 31, 2026 and december 31, 2025 8,512 and 7,324 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 1 | 1 | 1 | 1 |
| Additional paid-in capital | 1,988,697 | 1,983,361 | 1,981,822 | 1,979,114 |
| Accumulated other comprehensive income (loss) | 0 | 1 | 2 | 0 |
| Accumulated deficit | -2,026,010 | -2,021,865 | -2,018,459 | -2,014,156 |
| Total stockholders' equity (deficit) | -37,312 | -38,502 | -36,634 | -35,041 |
| Total liabilities and stockholders' equity (deficit) | 19,997 | 20,235 | 30,167 | 36,902 |
Atara Biotherapeutics, Inc. (ATRA)
Atara Biotherapeutics, Inc. (ATRA)